S308.3.007 Site # 212 — East Lansing, Michigan

S308.3.007 Site # 212 is a clinical research site located in East Lansing, Michigan, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

S308.3.007 Site # 212 has participated in 1 clinical trials.

Therapeutic areas: Advanced Stage Parkinson's Disease.

Sponsors: Solvay Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Lansing

Browse all research sites in Michigan · View every site in East Lansing

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for S308.3.007 Site # 212?

S308.3.007 Site # 212 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has S308.3.007 Site # 212 conducted?

S308.3.007 Site # 212 has 1 clinical trials on record. Their work covers Advanced Stage Parkinson's Disease.

Is S308.3.007 Site # 212 accredited by Crixeo Clinical Trials?

S308.3.007 Site # 212 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about S308.3.007 Site # 212?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.